Photo-induced Stevens-Johnson Syndrome due to sulfasalazine therapy

Annals of Pharmacotherapy

Volumn 37, Issue 9, 2003, Pages 1241-1243

  Borrás Blasco, Joaquín ^a   Navarro Ruiz, Andrés ^a   Matarredona, Jaime ^a   Devesa, Pedro ^a   Montesinos Ros, Amparo ^a   González Delgado, Mercedes ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Phototoxicity; Stevens Johnson syndrome; Sulfasalazine

Indexed keywords

DEFLAZACORT; DICLOFENAC; FOLINATE CALCIUM; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; MALE; PHOTOTOXICITY; POLYARTHRITIS; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; SUN EXPOSURE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS; HUMANS; MALE; STEVENS-JOHNSON SYNDROME; SULFASALAZINE; SUNLIGHT;

EID: 0042423740     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C271     Document Type: Article

References (16)

1. Pinal RS. Sulfasalazine in the rheumatic disease. Semin Arthritis Rheum 1988;17:246-59.
2. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129: 92-6.
3. Revuz JE, Roujeau JC. Advances in toxic epidermal necrolysis. Semin Cutan Med Surg 1996;15:258-66.
4. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
5. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
6. Carrion-Carrion C, Morales-Suarez-Varela MM, Llopis-Gonzalez A. Fatal Stevens-Johnson syndrome in an AIDS patient treated with sulfadiazine (letter). Ann Pharmacother 1999;33:379-80.
7. Gallais V, Grange F, De Bandt M, Crickx B, Belaich S. Salazosulfapyridine-induced eruption. Pustular erythroderma and pseudo-lymphomatous syndrome: 2 cases. Ann Dermatol Venereol 1994;121:11-4.
8. Jullien D, Wolkenstein P, Roupie E, Roujeau JC, Revuz J. Toxic epidermal necrolysis after sulfasalazine treatment of mild psoriatic arthritis: warning on the use of sulfasalazine for a new indication. Arthritis Rheum 1995;38:573.
9. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S, et al. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine. Am J Gastroenterol 1992;87:1654-7.
10. Veale DJ, Ho M, Morley KD. Sulphasalazine-induced lupus in psoriatic arthritis. Br J Rheumatol 1995;34:383-4.
11. Ljunggren B, Bjellerup M. Systemic drug photosensitivity. Photodermatol 1986;3:26-35.
12. Ortel B, Sivayathorn A, Honigsmann H. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Dermatologica 1989;178:39-42.
13. LeVine MJ. Erythema resulting from suberythemogenic doses of ultraviolet radiation and methotrexate. Arch Dermatol 1981;117:656-8.
14. Primka EJ, Camisa C. Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis. J Am Acad Dermatol 1997;36:815-8.
15. GISED: cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Dermatology 1993;186:164-9.
16. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.